16-4380938-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_138440.3(VASN):āc.61G>Cā(p.Val21Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,595,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_138440.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VASN | NM_138440.3 | c.61G>C | p.Val21Leu | missense_variant | 2/2 | ENST00000304735.4 | NP_612449.2 | |
CORO7 | NM_024535.5 | c.785+7048C>G | intron_variant | ENST00000251166.9 | NP_078811.3 | |||
CORO7-PAM16 | NM_001201479.2 | c.785+7048C>G | intron_variant | NP_001188408.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VASN | ENST00000304735.4 | c.61G>C | p.Val21Leu | missense_variant | 2/2 | 1 | NM_138440.3 | ENSP00000306864 | P1 | |
CORO7 | ENST00000251166.9 | c.785+7048C>G | intron_variant | 1 | NM_024535.5 | ENSP00000251166 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152146Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000313 AC: 7AN: 223344Hom.: 0 AF XY: 0.0000405 AC XY: 5AN XY: 123396
GnomAD4 exome AF: 0.000139 AC: 200AN: 1443068Hom.: 0 Cov.: 31 AF XY: 0.000141 AC XY: 101AN XY: 717146
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 11, 2023 | The c.61G>C (p.V21L) alteration is located in exon 2 (coding exon 1) of the VASN gene. This alteration results from a G to C substitution at nucleotide position 61, causing the valine (V) at amino acid position 21 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at